INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 158 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $403,000 | +6.1% | 7,405 | -61.3% | 0.00% | 0.0% |
| Q3 2020 | $380,000 | -5.5% | 19,132 | +0.1% | 0.00% | 0.0% |
| Q2 2020 | $402,000 | +75.5% | 19,116 | +2.2% | 0.00% | +100.0% |
| Q1 2020 | $229,000 | -16.4% | 18,704 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $274,000 | +9.6% | 18,704 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $250,000 | -18.3% | 18,704 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $306,000 | -4.1% | 18,704 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $319,000 | +41.2% | 18,704 | +136.3% | 0.00% | +100.0% |
| Q3 2018 | $226,000 | +4.6% | 7,914 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $216,000 | -2.3% | 7,914 | -31.3% | 0.00% | 0.0% |
| Q4 2017 | $221,000 | -22.7% | 11,516 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $286,000 | +55.4% | 11,516 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $184,000 | +13.6% | 11,516 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $162,000 | – | 11,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |